National Cancer Institute, Division of Cancer Prevention

12th EDRN Scientific Workshop (Virtual Via Zoom and gather.town) Deadline to register is Monday, March 15th, 2021.   The data fields with   sign are required. Please be complete and accurate when completing this form.     Verification Code:  If you do not know the Verification Code for this meeting, please contact EDRN DMCC Administrative Coordinator Royce Malnik at rmalnik@fredhutch.org, phone: 206-696-3005.     Attendee's Email Address:    First Name  Last Name  Degree  M.D. Ph.D. M.D., Ph.D. M.P.H. M.B.A. M.A. M.S. M.Sc. B.A. B.S. Sc.D. None Other (Specify) Other Degree EDRN Title  EDRN Principal Investigator EDRN Investigator NCI Program Director EDRN Associate Member Program Assistant Patient Advocate Other (Specify) Other Title Organization  Abbott Laboratories Agilent American International Biotechnology Services Arizona State University/The Biodesign Institute Baylor College of Medicine Beckman Coulter Beth Israel Deaconess Medical Center Bio-Rad Laboratories Boston University Brigham and Women`s Hospital British Columbia Cancer Agency British Columbia Cancer Research Centre Broad Institute at MIT and Harvard Canary Foundation Cancer Research Center of Hawaii, University of Hawaii Case Western Reserve University Celera Center for Prostate Disease Research, Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center Centers for Disease Control and Prevention City of Hope Commonwealth Biotechnologies, Inc Commonwealth Scientific & Industrial Research Organisation Cornell University Creatv MicroTech, Inc. Creighton University CRUK Cambridge Research Institute Dana-Farber Cancer Institute diaDexus Drexel University College of Medicine Duke University Medical Center Eastern Virginia Medical School Emory University Eppley Institute/University of Nebraska Medical Center Fox Chase Cancer Center Fred Hutchinson Cancer Research Center Geisel School of Medicine at Dartmouth Genteomics USA, Inc. Georgetown University GlaxoSmithKline H. Lee Moffitt Cancer Center and Research Institute Inc. Harborview Medical Center Harvard Medical School and Beth Israel Deaconess Medical Center Hologic Gen-Probe, Inc. Iceland Genomics Corporation Indiana University Insightful, Inc Institute for Molecular Systems Biology Johns Hopkins Medical Institutions Johns Hopkins University Johns Hopkins University Department of Urology Johns Hopkins University School of Medicine Karmanos Cancer Institute/Wayne State University Lakewood Pathology Associates Langone NYU Medical Center Lombardi Comprehensive Cancer Center Lovelace Respiratory Research Institute Massachusetts General Hospital Mayo Clinic Mayo Clinic-Jacksonville Memorial Sloan-Kettering Cancer Center Meso Scale Diagnostics, LLC Metabolon, Inc. Milagen, Inc. Miraculins Mount Sinai Medical Center Mount Sinai School of Medicine Mount Sinai Hospital Mountain Foundation for Lung Cancer/NASPCC NASA Jet Propulsion Laboratory NASPCC/Mountain Foundation For Lung Cancer National Cancer Institute National Cancer Institute at Frederick National Cancer Institute Tumor Glycome Laboratory National Center for Asbestos Related Disease National Institute of Standards and Technology National Institutes of Health New York University New York University School of Medicine North Dakota State University NorthShore University HealthSystem Northwestern University Northwestern University, Feinberg School of Medicine NOX Technologies Ohio State University College of Pharmacy Ohio State University Medical Center OncoMethylome Sciences Ontario Institute for Cancer Research Pacific Northwest National Laboratory Research Advocacy Network Roche Diagnostics SomaLogic Source MDx Stanford University Stanford University Medical Center The Ohio State University The Scripps Research Institute The University of Texas Health Science Center at San Antonio The University of Texas MD Anderson Cancer Center The Wistar Institute University of Alabama at Birmingham University of British Columbia University of California, Davis University of California, Irvine University of California, Los Angeles University of California, Norris Cancer Center University of California, San Diego University of California, San Francisco University of Chicago Urology Center University of Colorado Health Science Center University of Georgia University of Maryland, Baltimore University of Maryland School of Medicine University of Michigan University of Michigan Medical School University of Nebraska Medical Center University of New Mexico University of North Carolina at Chapel Hill University of Pennsylvania University of Pittsburgh University of Pittsburgh Cancer Institute University of Rochester Medical Center University of Texas Southwestern Medical Center University of Toronto University of Washington University of Western Australia Urological Sciences Research Foundation VA Medical Center Seattle Van Andel Research Institute Vanderbilt-Ingram Cancer Center Vanderbilt Medical Center Ventana Veridex, LLC Washington University Wayne State University Weill Cornell Medical College Weizmann Institute of Science Wistar Institute Yale University Other (Specify) Other Organization Type of Registrant  EDRN Member NCI Staff Guest City State/Province Telephone  (numbers only) Attendee's Contact Person Attendee's Contact Person Phone (numbers only) Attendee's Contact Person Email   CALL FOR ABSTRACTS FOR VIRTUAL POSTER SESSION: Workshop attendees (especially EDRN members) are encouraged to present posters at this Workshop. The Poster Session will take place using a 2D virtual/interactive platform called gather.town. Presenters may be available for live/interactive discussion during the poster session. In order to organize the session, the deadline to submit abstracts is Sunday, March 7, 2021. Please email poster abstracts to the EDRN DMCC at edrndmcc@fredhutch.org by this date. Abstracts must follow the format outlined in the Abstract Formats for Posters and Oral Presentations. Poster image size and format specifications will be sent to presenters soon. Final poster images will be due by March 15th in order to upload and organize the space. Poster Abstract Submission Please select Yes if you intend to submit a poster abstract; otherwise, please select No.  Yes No       12th EDRN Scientific Workshop Virtual Via Zoom and gather.town Tuesday-Thursday, March 23-25, 2021 Meeting Agenda: • 12th EDRN Scientific Workshop Agenda (draft) (pdf file) • 12th EDRN Scientific Workshop Agenda (draft) (webpage on the EDRN public portal)   Connecting via Zoom and gather.town: Information for connecting to Zoom and gather.town for the workshop will be available soon.   If you have any questions regarding meeting registration, please contact EDRN DMCC Administrative Coordinator Royce Malnik at rmalnik@fredhutch.org, phone: 206-696-3005 .

The meeting registration form created by EDRN DMCC at Fred Hutchinson Cancer Research Center ©